Clik here to view.
CORRECTING and REPLACING CANbridge Pharmaceutical Submits New Drug...
BEIJING Second sentence of first paragraph of release dated October 2, 2018, should read: The NMPA has accepted the NDA application. (instead of The NMPA has accepted the IND application.). The...
View ArticleClik here to view.
Dr. Reddy’s to Release Q2 FY19 Results on October 26, 2018
HYDERABAD, India Dr. Reddy’s Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will announce results for the quarter ended September 30, 2018 on Friday, October 26, 2018 after the Board Meeting....
View ArticleClik here to view.
Axcelead Drug Discovery Partners とERS Genomics、CRISPR /...
藤沢市 （ビジネスワイヤ）– Axcelead Drug Discovery Partners 株式会社社（代表取締役社長：池浦義典、本社：神奈川県藤沢市、以下「アクセリード」）とERS Genomics Limited（代表取締役社長：エリック・ローズ、本社：アイルランド ダブリン、以下「ERS」）は、ERSが管理するCRISPR /...
View ArticleClik here to view.
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9...
FUJISAWA, Japan & DUBLIN Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as “Axcelead”) and ERS Genomics Limited (hereinafter referred to as “ERS Genomics”) announced today a...
View ArticleClik here to view.
PHCホールディングス株式会社：米国・糖尿病技術協会の独自調査において、アセンシアの血糖自己測定システム「CONTOUR® NEXT...
東京 （ビジネスワイヤ） — PHCホールディングス株式会社（本社：東京都港区、代表取締役社長：小谷 秀仁）の100％子会社であるアセンシア ダイアベティスケアホールディングス株式会社（本社：スイス、バーゼル、以下「アセンシア」）が販売する血糖自己測定システム「CONTOUR® NEXT...
View ArticleClik here to view.
メダクタインターナショナルがFrancesco Siccardiを次期最高経営責任者に任命
スイス・カステルサンピエトロ （ビジネスワイヤ） — 革新的な人工関節置換術／脊椎手術関連製品の設計で世界をリードする家族所有の非上場企業メダクタインターナショナルは本日、著名な生物医学工学者でメダクタインターナショナルの現エグゼクティブバイスプレジデントのFrancesco...
View ArticleClik here to view.
FDA Approves Genentech’s Hemlibra (Emicizumab-kxwh) for Hemophilia A Without...
SOUTH SAN FRANCISCO, Calif. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Hemlibra®...
View ArticleClik here to view.
GI Dynamics Announces Selection of New Notified Body
BOSTON & SYDNEY GI Dynamics, Inc. (ASX:GID), a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the selection of...
View ArticleClik here to view.
Pivotal Parkinson’s Disease Clinical Trial Results Released at the...
HONG KONG PhotoPharmics today released the results of its multinational, double-blind, randomized controlled trial in Parkinson’s disease at the annual International Movement Disorders Society...
View ArticleClik here to view.
Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential...
MELBOURNE, Australia & SAN FRANCISCO Prana Biotechnology Ltd (ASX: PBT) (NASDAQ: PRAN) today announced further pre-clinical evidence for PBT434 will be presented in a poster at the International...
View ArticleClik here to view.
Valneva Receives FDA Approval for Accelerated Vaccine Dosing Schedule for...
GAITHERSBURG, Md. Valneva USA, the U.S. subsidiary of global vaccine biotech company Valneva SE, today announced U.S. Food and Drug Administration (FDA) approval of an accelerated dosing regimen for...
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品がCD30発現末梢性T細胞リンパ腫のフロントライン治療でアドセトリス（ブレンツキシマブ・ベドチン）を評価する第3相ECH...
米ワシントン州ボセル & マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
新研究评估Masimo ORi™能否帮助临床工作者减少ICU机械通气患者的高氧血症
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了一份摘要的结果，该摘要呈报于巴黎召开的法国麻醉复苏学会(SFAR) 2018年大会，法国CHU Angers的研究人员调查Masimo...
View ArticleClik here to view.
Visioneering Technologies, Inc. Enters European Market
ATLANTA Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, today announced that Medilens Nordic...
View ArticleClik here to view.
Clik here to view.
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement
FUJISAWA CITY, Japan & DUBLIN GenAhead Bio Incorporated (“GenAhead”) and ERS Genomics Limited (“ERS Genomics”) announced today a non-exclusive license agreement to provide GenAhead with access...
View ArticleClik here to view.
GenAhead Bio：ERS GenomicsとCRISPR / Cas9技術基本特許における非独占的ライセンス契約を締結
藤沢市 (美國商業資訊)–GenAhead Bio Incorporated（以下「GenAhead」）とERS Genomics Limited（以下「ERS Genomics」）は、GenAheadにERS Genomicが管理するCRISPR /...
View ArticleClik here to view.
PharmAbcine宣布FDA受理TTAC-0001用于治疗复发胶质母细胞瘤的IND申请
韩国大田 (美国商业资讯) — PharmAbcine, Inc是一家临床阶段生物技术公司，开发新型抗体治疗药物，用于多种癌症适应证，该公司宣布已收到美国食品药品管理局(FDA)针对其旗舰抗体TTAC-0001在研新药(“IND”)申请而签发的“可开展研究通知书”。该通知书允许公司开始启动美国临床试验单位开展贝伐珠单抗(Avastin®)难治复发GBM患者II期临床试验。...
View ArticleClik here to view.
Seattle Genetics与武田发布ADCETRIS® (Brentuximab...
华盛顿州博瑟尔、马萨诸塞州剑桥和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq:SGEN)与武田药品工业株式会社(TSE:4502)今天宣布，3期ECHELON-2临床试验达到主要终点。该试验显示，ADCETRIS (brentuximab...
View ArticleClik here to view.
Dr. Reddy’s Laboratories announces the launch of Colesevelam Hydrochloride...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it...
View Article